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New Findings 
1. What is the central question of this study? 
 
The isolation of cardiomyocytes and the homogenisation of myocardium are commonly performed 
on separate rodent hearts. We asked whether it might be viable to derive cells as well as whole 
muscle (homogenised or cryopreserved) from one organ. 
 
2. What is the main finding and its importance? 
We provide examples of six diverse experiments that can be performed using cells and tissue 
samples generated by a modified Langendorff technique. The volume and power of resultant data is 
increased and the method may be especially beneficial in models of cardiovascular disease. 
 
Abstract 
Researchers in biomedical sciences must continually re-evaluate their investment in experiments 
using laboratory animals. Our group is interested in various signalling pathways underlying 
physiological and pathophysiological function of the mammalian heart. Two important resources for 
this type of work are isolated cardiomyocytes and homogenised or preserved sections of whole 
myocardium. In order to ethically improve our experimental approach, we devised an adaptation of 
the Langendorff whole heart retrograde perfusion technique that allows the isolation of adult rat 
ventricular cardiomyocytes and processing/storage of myocardium from the same heart. This could 
result in a 50% reduction in the number of animals required for certain experiments. We believe that 
a generalised adoption of this method would represent a meaningful reduction of animal use in our 
field of research and, furthermore, strengthens datasets by permitting correlation between myocyte 
function and various parameters of myocardial biochemistry/structure in individual hearts. This 
approach is of particular relevance for studies of cardiac pathology, given the cost and time involved 
in generating experimental disease models. 
 
 
Introduction 
The use of animals in biomedical research permits the discovery of novel therapeutic approaches to 
the alleviation of human disease. A controlled legal framework makes the undertaking of such 
experiments impossible without strong justification [1]. Any justified approach includes the 
implementation of measures to limit the number of animals used. One research arena which 
critically depends on fresh tissue is cardiac (patho)physiology. A range of model systems, from 
isolated ventricular cardiomyocytes to the whole heart, have allowed major breakthroughs in basic 
science to instruct and inform treatments in the clinic.  
The isolation of cardiomyocytes is typically achieved through retrograde perfusion of hearts from 
small mammals (rat, mouse) with collagenase-containing solution in a Langendorff system [2][3]. 
Our laboratory routinely uses the isolated adult rat ventricular myocyte (ARVM) as a model for 
understanding fundamental signalling pathways in the heart, e.g. [4-6].  However, like many others, 
we also require intact myocardial samples for certain types of analysis. Myocardium is the preferred 
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source material for methods which require substantial quantities of protein from homogenates as 
well as assessment of intact muscle structure.  
Separate animals are normally used for cell isolation and processing of myocardial material. We 
outline here a simple modification of the Langendorff technique in which ventricular cardiomyocytes 
can be isolated and large sections of myocardium dissected from the same heart. This approach 
significantly expands the range of data that can be gathered from one experimental animal. We 
provide examples of six experiments that can be undertaken.  
 
Materials and methods 
Ethical approval. Appropriate approval was obtained from the University of Leeds’ Research Ethics 
Council. 
Experimental animals. Two adult (250-300 g) male Wistar rats were used according to guidelines set 
out in the Animals (Scientific Procedures) Act 1986.  
Modified Langendorff technique. Two researchers were required to efficiently perform this 
technique: one to isolate ARVM and the other to cryopreserve and homogenise myocardial tissue. 
The animal was humanely killed and the heart quickly excised and cannulated on a standard 
Langendorff retrograde perfusion assembly as described in [7]. The coronary circulation was 
perfused with HEPES-based isolation solution [IS (in mM): 130 NaCl, 5.4 KCl, 1.4 MgCl
2
, 0.4 NaH
2
PO
4
, 
10 creatine, 20 taurine, 10 glucose, 5 HEPES (pH 7.4)] containing 0.75 mM CaCl
2
. Immediately after 
the vessels had cleared of blood, the heart was cut transversely into two (basal and apical) sections. 
The position of the scission, at the midline from base to apex, was judged carefully in order to retain 
most of the right coronary and left anterior descending arteries in the basal section (Figure 1). The 
flat, cut edge of the basal section was brought into close contact with the bottom of a small (5 cm 
diameter) Petri dish. Along with the perfusate collecting in the dish, this provides a degree of back-
pressure that maintains adequate coronary artery perfusion.  After the section, two procedures 
were performed in parallel.  
(1) Perfusion of the mounted heart tissue was switched to IS containing 0.1 mM EGTA for 4 min, 
and then IS supplemented with digest enzymes:  1 mg/ml collagenase (type II; Worthington) 
plus 0.08 mg/ml protease (type XIV) for 7 min. The solution volume in the supporting dish 
was kept low to allow rapid exchange of solutions surrounding the heart. Once all EGTA had 
been flushed out of the vasculature, enzyme-containing IS was continually collected and 
returned to the supply reservoir for recirculation. After 7 min perfusion with enzyme, 
ventricular tissue was minced and agitated in enzyme-containing IS supplemented with 1% 
(
w
/
v
) BSA at 37°C under a continuous oxygen supply. Isolated cardiomyocytes were filtered 
from this suspension at 5 min intervals and resuspended in IS containing 0.75 mM Ca
2+
.   
(2) Around 450 mg of tissue – approximately half of the wet weight of an adult rat heart – was 
available for sample preparation by the second researcher.  The apical portion of the heart 
was minced and placed into one of two different buffers for immunoblotting or sucrose 
density gradient fractionation (SDGF).  For immunoblotting, ≈100 mg tissue was 
homogenised for 4 x 10 s in 2 ml cooled (≈15 ⁰C) Laemmli buffer without β-mercaptoethanol 
at maximum power (Ultra-Turrax T8 hand-held homogeniser, Ika) [7].  After the final 
homogenisation step, tubes were centrifuged (2000 g, 10 min at 15 ⁰C) to sediment cell 
debris and unprocessed material. The supernatant was immediately stored at -20 °C. For 
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SDGF ≈300 mg tissue was homogenised  for 6 x 20 s in 2.5 ml of 500 mM Na
2
CO
3
 solution (pH 
11.0; 4 ⁰C) containing protease inhibitor cocktail (Roche). Samples were stored at -20 °C. The 
remaining portion of tissue (≈50 mg) was snap frozen in liquid N
2
 for later biochemical 
analysis. Alternatively, this tissue could be frozen in isopentane, cooled to melting point over 
liquid N
2
, for sectioning.  
ARVM shortening and Ca
2+
 transient measurement. ARVM were loaded with fura-2 by incubation in 
IS containing 1.5 μM fura-2-AM for 10 min at room temperature.  Cell shortening and intracellular 
Ca
2+
 (Ca
2+
i
) transients were recorded using IonWizard6 software (IonOptix) as described previously 
[6].  
Electron microscopy (EM). ARVM were fixed in EM buffer (100 mM Na cacodylate, pH 7.3) containing 
2.5% (
v
/
v
) glutaraldehyde and stored at 4 °C until sample processing. EM was performed as described 
in [8]. Digital images were obtained using a Technai G
2
 Spirit microscope (FEI Company). 
Separation of ARVM cytosol, membranes, and myofilaments . Cells were disrupted and material 
separated into various fractions using the Subcellular Fractionation Kit from Pierce (Thermo Fisher 
Scientific).  
Myocardial homogenate discontinuous SDGF. Samples were sonicated for 6 x 10 s at maximum 
power (Vibra Cell, Sonics) on ice before fractionation on a discontinuous sucrose density gradient as 
recently described [5]. Protein expression and cholesterol levels in fractionated samples were 
measured by immunoblotting and Amplex Red assay (Invitrogen) respectively.  
Immunoblotting.  5% (
v
/
v
) β-mercaptoethanol was added to all samples prior to sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE). Proteins were transferred from 
polyacrylamide gels to polyvinylidene fluoride (PVDF) membranes, after which a standard 
immunoblotting procedure was employed [5].  
Materials. All materials were from Sigma-Aldrich unless stated otherwise. Primary antibodies raised 
against Hsp90 (#4875), Akt (#9272), troponin I (#4002), and phospho-troponin I (Ser23/24) (#4004) 
were from Cell Signalling Technology. Purified mouse anti-eNOS (#610296), anti-phospho-eNOS 
(Ser1177) (#612392), anti-caveolin 3 (#610421), anti-caveolin 1 (#610406) and anti-adaptin β 
(#610382) were from BD Biosciences. Anti-β2-AR antibody (#sc-569) was from Santa Cruz 
Biotechnology. Anti-Desmin (#M0760) antibody was from DAKO. 
 
Results  
Populations of ARVM isolated using the modified Langendorff method showed comparable viability 
(percentage of rod-shaped quiescent cells) to those isolated in the intact heart Langendorff system. 
The viability of previous ARVM isolations from the intact heart system was found to be 63.5 ± 4.7 % 
(n=8; mean ± S.D.). In the small number of experiments performed using the modified method, the 
ARVM viability fell within this range. There was also no overt difference in the amount of undigested 
tissue remaining following Langendorff perfusion on the intact versus truncated heart. Together 
these data suggest that perfusion of the coronary vasculature of the basal section is adequate and 
that this method does not compromise the number of cells isolated (per wet weight of 
myocardium).  
A wealth of material is generated using the method reported here; we focus on subsequent 
analytical techniques pertinent to our research aims. We have been able to isolate enough ARVM 
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from one basal section of heart to perform at least 3 different types of experiment. One of these is 
the simultaneous assessment of cell shortening and Ca
2+
i
 transients from fura-2-loaded individual 
cells. A typical recording is shown in Figure 2 (a); robust shortening (lower traces, black) and tightly 
controlled Ca
2+
i
 (upper traces, grey) are seen (which are further indications of cell viability). Only a 
relatively small number of cells are required for investigation of cell function in response to 
intervention (e.g. drug treatment). For another experiment, a small aliquot of cells was taken on the 
day of isolation, fixed in EM buffer and stored at 4 °C for subsequent processing and analysis. We are 
interested in caveolae, specialised invaginated membrane microdomains rich in cholesterol, 
sphingolipids and caveolin proteins. Figure 2 (b) shows a typical transmission EM image showing a 
section of surface sarcolemma with caveolae. Similar assessments could be made in sections of 
intact myocardium. As well as single cell analyses, ARVM can be pooled for further measurements. 
For example, we lysed ARVM populations and separated the lysate into cytosolic, membrane and 
insoluble phases using a commercially available kit (Figure 2 (c)). This type of procedure is useful for 
studying membrane localisation of proteins of interest.  As can be seen by specific labelling using 
marker proteins, there was a clean separation of phases. Using populations of cells in this way allows 
multiple experimental manoeuvres to be performed on a single heart. For example, we are 
interested in the migration of the small GTPase Rac1 from cytosol to membrane following agonist 
challenge with endothelin 1, so will be able determine its subcellular localisation before and after 
treatment. 
The generation of myocardial homogenates and preservation of ventricular muscle expands the 
range of information that can be gathered from one heart. Figure 2 (d) shows typical data from 
immunoblotting of homogenates to measure expression levels of total and phosphorylated cardiac 
troponin I (cTnI) and endothelial nitric oxide synthase (eNOS). Analysis can be extended to examine 
the distribution of proteins among the various membrane fractions obtained after SDGF. Figure 2 (e) 
illustrates representative data from SDGF with the buoyant caveolar fraction (6 in this instance) 
identified by the presence of caveolin-1 and -3 (Cav-1 and Cav-3) and non-caveolar fractions (heavy 
fractions 9-12; HF) indicated by the presence of β-adaptin. Samples generated in this way can 
additionally be used for other analyses, e.g. Figure 2 (f) shows the typical cholesterol concentration 
profile across myocardial membrane fractions and confirms its enrichment in the buoyant fraction.  
An experimental manoeuvre in the whole animal which might be expected to alter ARVM contractile 
parameters through changes in underlying biochemical properties or even cellular ultrastructure can 
easily be assessed by the array of experiments outlined above. Of course, an ARVM population from 
a whole heart can be split to provide source material for the same experiments but the amount of 
sample generated for SDGF/immunoblotting is comparatively scant. This occurs because of 
significant loss of tissue during the digestion process. For example, in our experience, ARVM from 
multiple hearts have to be pooled to generate sufficient sample to layer on a single sucrose density 
gradient.  
 
Discussion  
There are limitations in the application of this technique to certain animal models of cardiovascular 
disease. Whilst it could be suitable for any model characterised by global cardiomyopathy (e.g.  
hypertrophy/heart failure via aortic constriction), it would not be appropriate to use this for infarct 
models which target discrete areas of the heart since isolated cardiomyocytes from one region may 
not have undergone the same pathological progression as myocardium from a different region. 
6 
 
Where the success of myocyte isolation is already compromised (e.g.  diabetic cardiomyopathy or 
failure models), a conceivable drawback might be the potential for less viable populations of isolated 
ARVM than in the intact heart system. This, however, has not yet been tested. The inherent 
longitudinal bias in the technique could also affect comparison of cells and whole muscle (taken 
from apical and basal regions, respectively). For example, regional differences in L-type Ca
2+
 channel 
[9] and sodium-calcium exchanger [10] expression/activity have been reported. The interpretation of 
data derived from protein homogenates from whole ventricle must always incorporate the fact that 
cell types other than cardiomyocytes (cardiac fibroblasts, vascular smooth muscle cells, endothelial 
cells (EC)) are abundant in the source tissue. When examining proteins (like cTnI) which are 
expressed exclusively in cardiomyocytes, there should be no concern with ‘contamination’ from 
other cell sources. eNOS, for example, is found in EC as well as cardiomyocytes so quantification of 
protein level in ventricle homogenates reflects contributions from more than one cell type. 
However, in some situations, the express aim may be to quantify expression of ubiquitously 
expressed proteins in all tissues of the heart: the approach outlined here would accommodate such 
assessments. In principle the current technique could be applied to other rodent heart systems, but 
it remains untested in mouse heart, a source generally considered more difficult from which to 
obtain healthy myocytes.  
We have outlined a new procedure that yields, from a single rat heart, dissociated cardiomyocytes, 
cardiac muscle homogenates and cryopreserved tissue that can be used in a number of different 
applications. The examples we provide are not limiting but illustrate that this approach can produce 
multiple different streams of data that feed into a common research aim. This is advantageous 
because: (i) correlations can be made between cardiomyocyte function and numerous parameters of 
myocardial biochemistry in individual hearts and (ii) statistical power is increased.  Indeed, we 
consider that the reduction in animals required for a particular study that can be achieved by 
implementation of this modified Langendorff technique is of great relevance to studies of cardiac 
pathology, given the cost and time involved in generating experimental models of cardiac disease.  
Our technique could be incorporated into to a wider analytical framework to maximise the 
experimental observations made per heart. Such a framework could include in vivo monitoring of 
heart function with telemetry probes in an unrestrained animal, followed by echocardiography 
under anaesthesia, and culminate in modified Langendorff technique-derived cells and myocardial 
samples. 
It is hoped that other groups may test and, where suitable, adopt this method to reduce the use of 
experimental animals in basic cardiology research. 
 
Figure legends 
Figure 1. Scheme depicting the modified Langendorff set-up . Standard apparatus for retrograde 
perfusion of the whole heart according to Langendorff is shown. Three separate chambers (labelled 
1, 2, and 3) connected in series to a peristaltic pump allow successive switching of Ca
2+
-, EGTA-, and 
enzyme-containing solutions (see Materials and Methods). Standard myocyte dissociation is then 
performed on the basal section, whilst the apical section can be further dissected into right ventricle, 
septum and left ventricle. Tissue from the latter three sources is snap-frozen or homogenised. The 
upper rectangular inset shows a larger version of the stylised heart to indicate where the section is 
made (grey dashed line). Larger arterial vessels supplying the left ventricle are named in italics. 
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Figure 2. Examples of experiments performed on cell and muscle samples.  The upper panel shows 
representative data from experiments using isolated ARVM: A, Cell shortening and intracellular Ca
2+
 
transients in an individual fura-2 loaded ARVM; B, transmission EM of a sarcolemmal region from a 
single ARVM,  m indicates a mitochondrion, and z the sarcomeric z-line (18500x magnification); C, 
separation of cell populations into cytosolic (C), membrane (M), and insoluble (I) fractions 
demonstrated by the marker proteins heat-shock protein 90 (Hsp90), β2-AR and desmin, 
respectively;  10 μg protein was loaded per lane. The lower panel shows representative data from 
experiments carried out on myocardial homogenates: D, levels of total and phosphorylated cTnI and 
eNOS using immunoblotting; E, protein distribution in different membrane compartments separated 
by SDGF (Cav-1, caveolin 1; Cav-3, caveolin 3; β-adap, β adaptin; HF, heavy fractions 9-12); F, 
cholesterol distribution in different membrane fractions measured using Amplex Red cholesterol 
assay.   
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